SCHEMBL6861713

SCHEMBL6861713

CCc1ccccc1-c1n[nH]c(-c2ccc(OC)cc2)n1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 3/20 0.51
NR1H3 Q13133 3/20 0.51
KDM4E B2RXH2 2/20 0.50
TEK Q02763 1/20 0.46
ADORA2A P29274 2/20 0.45
ADORA3 P0DMS8 1/20 0.45
NPC1 O15118 4/20 0.44
RAB9A P51151 4/20 0.44
TP53 P04637 3/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
HPGD P15428 3/20 0.44
ALDH1A1 P00352 2/20 0.44
DGAT1 O75907 1/20 0.43
MAPT P10636 3/20 0.43
ADORA1 P30542 1/20 0.43
CCNE2 O96020 1/20 0.42
CDK4 P11802 1/20 0.42
CCND1 P24385 1/20 0.42
CCNE1 P24864 1/20 0.42
CDK2 P24941 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5678433 0.86 NR1H2 (0.64) NR1H2NR1H3TEKADORA2AADORA1
SCHEMBL6861707 0.81 ALDH1A1 (0.57) NPC1RAB9AALDH1A1MAPTLMNA
SCHEMBL15025693 0.79 NR1H2 (0.73) NR1H2NR1H3KDM4EADORA2AADORA3
SCHEMBL3500575 0.79 NR1H2 (0.68) NR1H2NR1H3TEKADORA2ANPC1
SCHEMBL29366389 0.79 NR1H2 (0.68) NR1H2NR1H3TEKADORA2ANPC1
SCHEMBL15117068 0.78 KDM4E (0.67) NR1H2NR1H3KDM4EADORA2ANPC1
SCHEMBL5681247 0.77 TRPA1 (0.40) KDM4ETEKADORA2ANPC1RAB9A
SCHEMBL13675365 0.76 ABL1 (0.56) KDM4ETEKNPC1RAB9ATP53
SCHEMBL8513868 0.76 NR1H2 (0.53) NR1H2NR1H3KDM4EADORA2AADORA3
SCHEMBL10943615 0.75 NR1H2 (0.63) NR1H2NR1H3ADORA2AADORA1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6797722-B2 Use of 3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole for the treatment of autoimmune diseases SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 2004-09-28 US disclosed